According to a research note from UBS Investment Research, despite expected short-term gains Unilever faces a number of significant challenges that it must overcome on the road to recovery.
Go deeper with GlobalData
According to UBS analyst Alan Erskine, Unilever’s second quarter sales are likely to grow 3.3% to EUR10.25bn (US$12.88bn). “In Q2 we anticipate organic sales growth of 3.6% (3.1% volume/mix), driven largely by another strong performance in the emerging markets,” the note stated.
Shares of the Netherlands-based company have dropped by 9% in value since it reported weak first quarter results in May. The share has “fallen to a level where we consider them to be slightly oversold,” Erskine observed.
However, the research note continued: “we remain sceptical of any meaningful recovery”.
Erskine said that Unilever’s poor performance is the result of corporate culture issues. “We believe the causes of Unilever’s marketplace underperformance have a lot to do with corporate culture and may not be easily addressed,” he commented.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataMoreover, UBS warned of increasing competition from Procter & Gamble.
UBS maintained a “neutral” rating and a price target of US$24.03.
Unilever is scheduled to report second-quarter 2006 results on 3 August.
